glp-1 for metabolic syndrome glp 1 receptor agonists type 2 diabetes GLP-1-based therapies diabetes: from single, dual GLP-1 Biomarkers in the Development

Theyre good treatments, but theyre not great treatments. Ciccarone said theres been enough evidence on the use of GLP-1s and alcohol addiction so far to support its effectiveness, but hes skeptical of its application for stimulant-use disorder

Based on the trends in CDERs FY 2025 activity, there are a few practical steps regulatory and quality leaders should consider here: Tighten supply chain and vendor controls

Standardization provides a sense of transparency and certainty about the product you're using, which is a definite upside with any consumer product

Microbial metabolites have emerged as critical modulators of immune responses, influencing therapeutic outcomes